Cargando…
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory
Radiation therapy (XRT) has a well-established role in cancer treatment. Given the encouraging results on immunostimulatory effects, radiation has been increasingly used with immune-check-point inhibitors in metastatic disease, especially when immunotherapy fails due to tumor immune evasion. We hypo...
Autores principales: | Sezen, Duygu, Barsoumian, Hampartsoum B., He, Kewen, Hu, Yun, Wang, Qi, Abana, Chike O., Puebla-Osorio, Nahum, Hsu, Ethan Y., Wasley, Mark, Masrorpour, Fatemeh, Wang, Jing, Cortez, Maria Angelica, Welsh, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582356/ https://www.ncbi.nlm.nih.gov/pubmed/36275767 http://dx.doi.org/10.3389/fimmu.2022.984318 |
Ejemplares similares
-
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer
por: He, Kewen, et al.
Publicado: (2021) -
A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model
por: Hu, Yun, et al.
Publicado: (2021) -
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
por: Younes, Ahmed I., et al.
Publicado: (2020) -
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2022) -
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
por: Hu, Yun, et al.
Publicado: (2022)